HPLC Method Development and Validation for the Determination of Apixaban and Clopidogrel in Novel Fixed-Dose Combination Tablets

HPLC Method Development and Validation for the Determination of Apixaban and Clopidogrel in Novel Fixed-Dose Combination Tablets

A simple, fast, and accurate high-performance liquid chromatographic (HPLC) method is developed, optimized, and validated for a fixed-dose combination of apixaban (APX) and clopidogrel (CLOP) tablets according to ICH guidelines. Chromatographic separation of the drugs was performed on a BDS Hypersil...

Full description

Bibliographic Details
Main Authors:	Ni’meh Al-Shami, Hani Naseef, Ramzi Moqadi, Feras Kanaze
Format:	Article
Language:	English
Published:	Hindawi Limited 2024-01-01
Series:	Journal of Chemistry
Online Access:	http://dx.doi.org/10.1155/2024/2675736

Similar Items

Fixed combination of rivaroxaban and Aspirin: Tablet formulation and analytical method validation
by: Hani Naseef, et al.
Published: (2024-08-01)

The acceptance and awareness of healthcare providers towards doctor of pharmacy (Phram D) in the Palestinian health care system
by: Hani Naseef, et al.
Published: (2020-09-01)

An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets
by: Eman A. Mostafa, et al.
Published: (2023-11-01)

Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine
by: Abukhalil AD, et al.
Published: (2023-03-01)

Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
by: Abdallah Damin Abukhalil, et al.
Published: (2023-01-01)

A green HPLC method for the determination of apixaban in pharmaceutical products: Development and validation
by: Akbel Erten, et al.
Published: (2023-08-01)

Design of trio-colored validated HPLC method for synchronized multianalyte quantitation of four top selling antihyperlipidemic drugs in different fixed-dose combined tablets
by: Haydi S. Elbordiny, et al.
Published: (2024-03-01)

Development of stability indicating, validated single dissolution method for simultaneous estimation of clopidogrel bisulfate and rivaroxaban in tablet dosage formulation by RP-HPLC method
by: Rupali Sajjanwar, et al.
Published: (2015-01-01)

DETERMINATION AND VALIDATION OF MEBHYDROLINE NAPADISYLATE IN TABLETS BY HPLC
by: Perpustakaan UGM, i-lib
Published: (2008)

DETERMINATION AND VALIDATION OF MEBHYDROLINE NAPADISYLATE IN TABLETS BY HPLC
by: Lestyo Wulandari
Published: (2010-06-01)

Development and validation of an HPLC–MS/MS method to determine clopidogrel in human plasma
by: Gangyi Liu, et al.
Published: (2016-01-01)

Massive Intoxication with 70 Tablets of Apixaban: A Case Report
by: Tadahiro Kobayashi, et al.
Published: (2023-09-01)

Quantitative Analysis of Favipiravir by HPLC: Development and Validation
by: Moammal Qurt, et al.
Published: (2023-01-01)

Formulation and evaluation of orally disintegrating clopidogrel tablets
by: Gamal Mohamed Mahrous, et al.

Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross-Sectional Study, Palestine
by: Abdallah Damin Abukhalil, et al.
Published: (2024-01-01)

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis
by: Blomberg Bjørn, et al.
Published: (2001-01-01)

Clinical outcomes of COVID-19 in hemodialysis patients
by: Lina Adwan, et al.
Published: (2023-11-01)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
by: Ghim JL, et al.
Published: (2019-05-01)

A validated reverse phase hplc method for the simultaneous estimation of clopidogrel bisulfate and rivaroxaban in pharmaceutical application
by: Rupali Sajjanwar, et al.
Published: (2015-11-01)

Method development and validation of aspirin and clopidogrel pharmaceutical dosage forms by developing new RP HPLC method
by: Nellore Dharani Sai Sreekanth, et al.
Published: (2020-08-01)

Development and Validation of HPLC Method for Identification of Ramipril in Printed Tablets and Filaments
by: V. V. Tihonova, et al.
Published: (2022-11-01)

Development and validation of HPLC and UV spectrophotometric methods for the determination of lumiracoxib in tablets
by: T.S. Moreira, et al.
Published: (2008-09-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Medication error awareness among health care providers in Palestine: A questionnaire-based cross-sectional observational study
by: Abdallah Damin Abukhalil, et al.
Published: (2022-04-01)

Development and validation of a normal-phase HPTLC method for the simultaneous analysis of Lamivudine and Zidovudine in fixed-dose combination tablets
by: Palani Venkatesh, et al.
Published: (2012-04-01)

Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets.
by: Thomas Pouplin, et al.
Published: (2014-01-01)

Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
by: Stephen R. Mandt, et al.
Published: (2022-05-01)

Validation of a dissolution method with RP-HPLC analysis for Perindopril erbumine and Indapamide combination tablet
by: Jain P.S., et al.
Published: (2012-01-01)

Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Risk of developing depression among breast cancer patients in Palestine
by: Dana Sadaqa, et al.
Published: (2022-03-01)

Experimental design approach for the development and validation of an enantiospecific RP-HPLC method for simultaneous determination of clopidogrel and related compounds
by: Rumenka Petkovska, et al.
Published: (2008-06-01)

Comparisons of physical properties and rates of rifampicin dissolution in Fixed Dose Combination (2FDC) tablet against rifampicin tablet
by: Normalitasari Ayu Damayanti, et al.
Published: (2019-12-01)

Chromatographic determination of clopidogrel bisulfate; detection and quantification of counterfeit Plavix® tablets
by: Mona E. ElTantawy, et al.
Published: (2014-06-01)

Multilayer-Coated Tablet of Clopidogrel and Rosuvastatin: Preparation and In Vitro/In vivo Characterization
by: Ki-Soo Seo, et al.
Published: (2019-07-01)

Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
by: Choi HK, et al.
Published: (2016-10-01)

VALIDATION OF A SIMPLE REVERSED PHASE-HPLC METHOD FOR THE DETERMINATION OF BACLOFEN IN TABLETS
by: Juliana dos Santos, et al.
Published: (2018-12-01)

VALIDATION OF A SIMPLE REVERSED PHASE-HPLC METHOD FOR THE DETERMINATION OF BACLOFEN IN TABLETS
by: Juliana dos Santos, et al.
Published: (2018-12-01)

VALIDATION OF A SIMPLE REVERSED PHASE-HPLC METHOD FOR THE DETERMINATION OF BACLOFEN IN TABLETS
by: Juliana dos Santos, et al.
Published: (2018-12-01)

VALIDATION OF A SIMPLE REVERSED PHASE-HPLC METHOD FOR THE DETERMINATION OF BACLOFEN IN TABLETS
by: Juliana dos Santos, et al.
Published: (2018-12-01)